Studying Adipose Endothelial Cell/Adipocyte Cross-Talk in Human Subcutaneous Adipose Tissue.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
05 Apr 2024
Historique:
medline: 22 4 2024
pubmed: 22 4 2024
entrez: 22 4 2024
Statut: epublish

Résumé

Microvascular endothelial cells (MVECs) have many critical roles, including control of vascular tone, regulation of thrombosis, and angiogenesis. Significant heterogeneity in endothelial cell (EC) genotype and phenotype depends on their vascular bed and host disease state. The ability to isolate MVECs from tissue-specific vascular beds and individual patient groups offers the opportunity to directly compare MVEC function in different disease states. Here, using subcutaneous adipose tissue (SAT) taken at the time of insertion of cardiac implantable electronic devices (CIED), we describe a method for the isolation of a pure population of functional human subcutaneous adipose tissue MVEC (hSATMVEC) and an experimental model of hSATMVEC-adipocyte cross-talk. hSATMVEC were isolated following enzymatic digestion of SAT by incubation with anti-CD31 antibody-coated magnetic beads and passage through magnetic columns. hSATMVEC were grown and passaged on gelatin-coated plates. Experiments used cells at passages 2-4. Cells maintained classic features of EC morphology until at least passage 5. Flow cytometric assessment showed 99.5% purity of isolated hSATMVEC, defined as CD31

Identifiants

pubmed: 38647333
doi: 10.3791/66608
doi:

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Oliver I Brown (OI)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Katherine I Bridge (KI)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Sam Straw (S)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Natallia Makava (N)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Jason Scragg (J)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Sunti Limumpornpetch (S)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Cheukyau Luk (C)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Jessica Smith (J)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Anna Skromna (A)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Alexander F Bruns (AF)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Piruthivi Sukumar (P)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Lee D Roberts (LD)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Richard Cubbon (R)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Klaus K Witte (KK)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Stephen Wheatcroft (S)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds.

Mark T Kearney (MT)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds; m.t.kearney@leeds.ac.uk.

Classifications MeSH